DK0839196T3 - Humant CTLA-8 og anvendelser af CTLA-8-relaterede proteiner - Google Patents

Humant CTLA-8 og anvendelser af CTLA-8-relaterede proteiner

Info

Publication number: DK0839196T3
Authority: DK; Denmark
Prior art keywords: ctla; acid sequence; amino acid; seq; related proteins
Prior art date: 1995-07-19

Application number

DK96927237T

Other languages

English (en)

Inventor

Kenneth Jacobs

Samuel Goldman

Kerry Kelleher

Mckeough Carlin

Debra Pittman

Sha Mi

Steven Neben

Joann Giannotti

Margaret Golden-Fleet

Original Assignee

Inst Genetics Llc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-07-19

Filing date

1996-07-18

Publication date

2005-09-12

1995-08-11 Priority claimed from US08/514,014 external-priority patent/US5707829A/en

1996-07-18 Application filed by Inst Genetics Llc filed Critical Inst Genetics Llc

2005-09-12 Application granted granted Critical

2005-09-12 Publication of DK0839196T3 publication Critical patent/DK0839196T3/da

Links

108050003558 Interleukin-17 Proteins 0.000 title abstract 2
102000013691 Interleukin-17 Human genes 0.000 title abstract 2
102000004169 proteins and genes Human genes 0.000 title abstract 2
108090000623 proteins and genes Proteins 0.000 title abstract 2
101000998146 Homo sapiens Interleukin-17A Proteins 0.000 title 1
125000003275 alpha amino acid group Chemical group 0.000 abstract 6
150000001413 amino acids Chemical class 0.000 abstract 3
108090001005 Interleukin-6 Proteins 0.000 abstract 1
108090001007 Interleukin-8 Proteins 0.000 abstract 1
239000012634 fragment Substances 0.000 abstract 1
230000006698 induction Effects 0.000 abstract 1
230000014399 negative regulation of angiogenesis Effects 0.000 abstract 1
230000028327 secretion Effects 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
General Chemical & Material Sciences (AREA)
Public Health (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
Diabetes (AREA)
Virology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Tropical Medicine & Parasitology (AREA)
Pulmonology (AREA)
Molecular Biology (AREA)
Hematology (AREA)
Gastroenterology & Hepatology (AREA)
Rheumatology (AREA)
Physical Education & Sports Medicine (AREA)
Orthopedic Medicine & Surgery (AREA)
Endocrinology (AREA)
Neurology (AREA)
Emergency Medicine (AREA)
Biochemistry (AREA)
AIDS & HIV (AREA)
Ophthalmology & Optometry (AREA)
Biomedical Technology (AREA)
Obesity (AREA)
Neurosurgery (AREA)
Biotechnology (AREA)
Transplantation (AREA)
Heart & Thoracic Surgery (AREA)

DK96927237T 1995-07-19 1996-07-18 Humant CTLA-8 og anvendelser af CTLA-8-relaterede proteiner DK0839196T3 (da)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US50403295A	1995-07-19	1995-07-19
US08/514,014 US5707829A (en)	1995-08-11	1995-08-11	DNA sequences and secreted proteins encoded thereby
PCT/US1996/011889 WO1997004097A2 (en)	1995-07-19	1996-07-18	Human ctla-8 and uses of ctla-8-related proteins

Publications (1)

Publication Number	Publication Date
DK0839196T3 true DK0839196T3 (da)	2005-09-12

Family

ID=27054704

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK96927237T DK0839196T3 (da)	1995-07-19	1996-07-18	Humant CTLA-8 og anvendelser af CTLA-8-relaterede proteiner

Country Status (10)

Country	Link
EP (2)	EP1591529A3 (da)
JP (3)	JPH11510045A (da)
AT (1)	ATE295414T1 (da)
AU (1)	AU727480B2 (da)
CA (1)	CA2227220A1 (da)
DE (1)	DE69634726T2 (da)
DK (1)	DK0839196T3 (da)
ES (1)	ES2242966T3 (da)
PT (1)	PT839196E (da)
WO (1)	WO1997004097A2 (da)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6274711B1 (en)	1993-06-14	2001-08-14	Inserm, Institut National De La Sante Et De La Recherche Medicale	Purified mammalian CTLA-8 antigens and related reagents
US5707829A (en) *	1995-08-11	1998-01-13	Genetics Institute, Inc.	DNA sequences and secreted proteins encoded thereby
WO1998039448A2 (en) *	1997-03-07	1998-09-11	Human Genome Sciences, Inc.	186 human secreted proteins
WO1998054963A2 (en) *	1997-06-06	1998-12-10	Human Genome Sciences, Inc.	207 human secreted proteins
US7053190B2 (en)	1997-03-07	2006-05-30	Human Genome Sciences, Inc.	Secreted protein HRGDF73
US6878687B1 (en)	1997-03-07	2005-04-12	Human Genome Sciences, Inc.	Protein HMAAD57
US6420526B1 (en)	1997-03-07	2002-07-16	Human Genome Sciences, Inc.	186 human secreted proteins
EP1352962A1 (en) *	1997-03-07	2003-10-15	Human Genome Sciences, Inc.	186 human secreted proteins
WO1998039446A2 (en) *	1997-03-07	1998-09-11	Human Genome Sciences, Inc.	70 human secreted proteins
JP2001522239A (ja)	1997-03-21	2001-11-13	ヒューマンジノームサイエンシーズ，インコーポレイテッド	８７個のヒト分泌タンパク質
EP0973896A2 (en) *	1997-04-10	2000-01-26	Genetics Institute, Inc.	SECRETED EXPRESSED SEQUENCE TAGS (sESTs)
JP2001519666A (ja) *	1997-04-10	2001-10-23	ジェネティックス・インスチチュート・インコーポレーテッド	分泌発現配列タグ（ｓＥＳＴｓ）
EP0973899A2 (en) *	1997-04-10	2000-01-26	Genetics Institute, Inc.	SECRETED EXPRESSED SEQUENCE TAGS (sESTs)
EP1428833A3 (en) *	1997-06-06	2004-07-07	Human Genome Sciences, Inc.	207 human secreted proteins
US6548633B1 (en)	1998-12-22	2003-04-15	Genset, S.A.	Complementary DNA's encoding proteins with signal peptides
US6562578B1 (en)	1999-01-11	2003-05-13	Schering Corporation	IL-17-like cytokine binding compounds and antibodies
AU2783899A (en) *	1998-02-26	1999-09-15	Human Genome Sciences, Inc.	36 human secreted proteins
US7223727B2 (en)	1998-04-09	2007-05-29	Serono Genetics Institute S.A.	GSSP4 polynucleotides and polypeptides and uses thereof
US7060479B2 (en)	1999-12-08	2006-06-13	Serono Genetics Institute, S.A.	Full-length human cDNAs encoding potentially secreted proteins
US6251583B1 (en)	1998-04-27	2001-06-26	Schering Corporation	Peptide substrates for HCV NS3 protease assays
AU740405B2 (en)	1998-05-15	2001-11-01	Genentech Inc.	IL-17 homologous polypeptides and therapeutic uses thereof
US7771719B1 (en)	2000-01-11	2010-08-10	Genentech, Inc.	Pharmaceutical compositions, kits, and therapeutic uses of antagonist antibodies to IL-17E
EP1082433A4 (en) *	1998-05-29	2003-01-02	Human Genome Sciences Inc	Interleukins 21 and 22
CA2331154A1 (en) *	1998-06-16	1999-12-23	Human Genome Sciences, Inc.	Polypeptides having sequence identity with acid labile subunit of insulin-like growth factor
EP1097199A4 (en) *	1998-07-15	2005-02-23	Human Genome Sciences Inc	71 HUMAN SECRETED PROTEINS
US7091315B1 (en)	1998-07-15	2006-08-15	Human Genome Sciences, Inc.	Protein HDPBQ71
DK1114156T3 (da) *	1998-09-17	2008-03-03	Zymogenetics Inc	Transformerende vækstfaktor Beta-9 (ZTGFSS9) fra pattedyr
EP2341144A1 (en) *	1999-01-11	2011-07-06	Schering Corporation	Interleukin-17 related mammalian cytokines. Polynucleotides encoding them. Uses
CA2296792A1 (en) *	1999-02-26	2000-08-26	Genset S.A.	Expressed sequence tags and encoded human proteins
EP1053751A1 (en) *	1999-05-17	2000-11-22	Institut National De La Sante Et De La Recherche Medicale (Inserm)	Compositions and methods for treating cell proliferation disorders
EP1244683A4 (en) *	1999-11-12	2005-01-12	Human Genome Sciences Inc	21 HUMAN SECRETED PROTEINS
JP2003516150A (ja)	1999-12-08	2003-05-13	ジェンセット	潜在性分泌タンパク質をコードする全長ヒトｃＤＮＡ
AU2001241816A1 (en) *	2000-02-29	2001-09-12	Zymogenetics Inc.	Methods for promoting production of myelin by schwann cells
US7718397B2 (en)	2000-03-21	2010-05-18	Genentech, Inc.	Nucleic acids encoding receptor for IL-17 homologous polypeptides and uses thereof
DE60136921D1 (de) *	2000-04-18	2009-01-22	Schering Corp	Medizinische Verwendung von IL-174 Agonisten und Antagonisten
US20030096969A1 (en)	2000-06-02	2003-05-22	Genentech, Inc.	Secreted and transmembrane polypeptides and nucleic acids encoding the same
CN1329090A (zh) *	2000-06-21	2002-01-02	上海博德基因开发有限公司	一种新的多肽——人自身免疫疾病相关蛋白10和编码这种多肽的多核苷酸
CA2425506A1 (en) *	2000-10-18	2002-08-01	Immunex Corporation	Methods for treating rheumatoid arthritis using il-17 antagonists
WO2003034984A2 (en) *	2001-10-19	2003-05-01	Genentech, Inc.	Compositions and methods for the diagnosis and treatment of inflammatory bowel disorders
JP2011516026A (ja) *	2002-11-26	2011-05-26	ジェネンテック・インコーポレーテッド	免疫関連疾患の治療のための組成物と方法
EP2784084B2 (en) *	2003-07-08	2023-10-04	Novartis Pharma AG	Antagonist antibodies to IL-17A/F heterologous polypeptides
HUE026260T2 (en)	2003-11-21	2016-06-28	Ucb Biopharma Sprl	A method for treating multiple sclerosis by inhibiting IL-17 activity
GB0417487D0 (en) *	2004-08-05	2004-09-08	Novartis Ag	Organic compound
EP1996622A2 (en)	2006-03-10	2008-12-03	Zymogenetics, Inc.	Antibodies that bind both il-17a and il-17f and methods of using the same
US7790163B2 (en)	2006-03-10	2010-09-07	Zymogenetics, Inc.	Antibodies that bind both IL-17A and IL-17F and methods of using the same
US7767206B2 (en)	2006-10-02	2010-08-03	Amgen Inc.	Neutralizing determinants of IL-17 Receptor A and antibodies that bind thereto
EP2150564A2 (en)	2007-04-27	2010-02-10	ZymoGenetics, Inc.	Antagonists to il-17a, il-17f, and il-23p19 and methods of use
RU2474588C2 (ru)	2008-05-05	2013-02-10	Новиммун Са	Перекрестно-реактивные антитела анти-il-17a/il-17f и способы их применения
CN102458437B (zh)	2009-05-05	2015-06-10	诺维莫尼公司	抗il-17f抗体及其使用方法
EP2432493A1 (en) *	2009-05-20	2012-03-28	INSERM (Institut National de la Santé et de la Recherche Médicale)	Use of il-17 polypeptides for use in the prevention or treatment of atherosclerosis
PH12012501364A1 (en)	2010-01-15	2012-10-22	Amgen K A Inc	Antibody formulation and therapeutic regimens
ME02734B (me)	2011-01-14	2017-10-20	Ucb Biopharma Sprl	Antitelo koje vezuje il-17a i il-17f
UA117218C2 (uk)	2011-05-05	2018-07-10	Мерк Патент Гмбх	Поліпептид, спрямований проти il-17a, il-17f та/або il17-a/f

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6562333B1 (en) *	1993-06-14	2003-05-13	Schering Corporation	Purified mammalian CTLA-8 antigens and related reagents
NZ306653A (en) *	1995-03-23	1999-03-29	Immunex Corp	Isolated dna il-17 receptors
US5707829A (en) *	1995-08-11	1998-01-13	Genetics Institute, Inc.	DNA sequences and secreted proteins encoded thereby

1996
- 1996-07-18 DE DE69634726T patent/DE69634726T2/de not_active Expired - Lifetime
- 1996-07-18 WO PCT/US1996/011889 patent/WO1997004097A2/en not_active Ceased
- 1996-07-18 AU AU67123/96A patent/AU727480B2/en not_active Ceased
- 1996-07-18 EP EP05009086A patent/EP1591529A3/en not_active Withdrawn
- 1996-07-18 CA CA002227220A patent/CA2227220A1/en not_active Abandoned
- 1996-07-18 DK DK96927237T patent/DK0839196T3/da active
- 1996-07-18 JP JP9506846A patent/JPH11510045A/ja not_active Withdrawn
- 1996-07-18 EP EP96927237A patent/EP0839196B1/en not_active Expired - Lifetime
- 1996-07-18 AT AT96927237T patent/ATE295414T1/de not_active IP Right Cessation
- 1996-07-18 ES ES96927237T patent/ES2242966T3/es not_active Expired - Lifetime
- 1996-07-18 PT PT96927237T patent/PT839196E/pt unknown
2007
- 2007-11-21 JP JP2007301924A patent/JP4319686B2/ja not_active Expired - Fee Related
2009
- 2009-04-02 JP JP2009090326A patent/JP2009197000A/ja active Pending

Also Published As

Publication number	Publication date
AU6712396A (en)	1997-02-18
DE69634726D1 (de)	2005-06-16
JP2009197000A (ja)	2009-09-03
MX9800507A (es)	1998-05-31
WO1997004097A2 (en)	1997-02-06
PT839196E (pt)	2005-09-30
AU727480B2 (en)	2000-12-14
ES2242966T3 (es)	2005-11-16
CA2227220A1 (en)	1997-02-06
EP1591529A2 (en)	2005-11-02
EP0839196B1 (en)	2005-05-11
JP2008131942A (ja)	2008-06-12
JP4319686B2 (ja)	2009-08-26
JPH11510045A (ja)	1999-09-07
WO1997004097A3 (en)	1997-09-12
ATE295414T1 (de)	2005-05-15
EP1591529A3 (en)	2005-11-09
EP0839196A2 (en)	1998-05-06
DE69634726T2 (de)	2006-05-04

Publication	Publication Date	Title
DK0839196T3 (da)	2005-09-12	Humant CTLA-8 og anvendelser af CTLA-8-relaterede proteiner
NO20074516L (no)	2000-07-20	Pattedyrcytokinlignende polypeptid-1
ATE536406T1 (de)	2011-12-15	Neuartiger zytokin-zcytor17-ligand
DK35593D0 (da)	1993-03-26	Polypeptid kodet af lav-dna-sekvens
DK150992A (da)	1992-12-17	Fremgangsmaade til fremstilling af et polypeptidfragment af faktor viii:c, dna-sekvens og ekstrachromosomalt element indeholdende en saadan dna-sekvens, som koder herfor
DE3770915D1 (de)	1991-07-25	Menschliches apolipoprotein a1 sowie dessen variante, exprimiert in escherichia coli.
ATE378408T1 (de)	2007-11-15	Transformierender wachstumsfaktor beta-9 (ztgfss9) aus säugetieren
DK1908772T3 (da)	2012-03-19	Polypeptider og polynucleinsyrer af phorphorymonas gingivalis
ATE482272T1 (de)	2010-10-15	Zytokinproteinfamilie
ATE339878T1 (de)	2003-12-15	Myc-bindende zinkfinger-proteine, ihre herstellung und ihre verwendung
DK0728208T3 (da)	2003-07-21	Tomat-xyloglucan-endo-transglycosylase
DK0580672T3 (da)	1997-07-07	Syntetisk CDw52-(CAMPATH-1)-peptidantigen
DE59109235D1 (de)	2002-05-29	Peptide des HIV-gag Proteins, ihre Herstellung und Verwendung
DK1847607T3 (da)	2011-07-18	Antistoffer mod p51-protein
EP1295943A4 (en)	2005-11-16	POLYPEPTIDES CAPABLE THE POWER TO STIMULATE NEUTROPHILES
TH30275A (th)	1998-10-10	โปรตีนดัดแปลง